CEI Wins $500,000 for Consumers in Similasan Corp. Class Action

The U.S. District Court of the Southern District of California recently granted preliminary approval of a much improved class action settlement in Allen v. Similasan. The underlying suit alleged Similasan falsely marketed its homeopathic products as “Naturally Effective & Safe,” and violated FDA regulations, among other claims.
In a victory for the Competitive Enterprise Institute’s Center for Class Action Fairness (CCAF), the new settlement provides a $700,000 fund, which will provide more than $500,000 in relief to class members, a result of CCAF’s involvement in the case. The new settlement also reduces the attorneys’ original, excessive windfall to 25 percent of that fund.
“I’m happy my objection sent the parties back to the negotiating table and resulted in hundreds of thousands of dollars in cash relief for the class,” said objector and Center for Class Action Fairness attorney Frank Bednarz.
The original settlement gave attorneys a $545,000 payday, while the class members received nothing but

Continue Reading....

Check Also

Trump Meets With Italy’s Prime Minister After Refusing To Sign His Global Warming Pledge

Facebook Twitter Google+ Pinterest LinkedIn Digg Del StumbleUpon E-mail Reddit Buffer Love ThisThe Daily Caller …

Leave a Reply

Send this to friend